30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
EEO-1 filers must submit EEO-1 Component 2 (compensation and hours worked) data for years 2017 and 2...
Read More >
Bricker & Eckler's construction attorneys are proud to present "Top Gun," our premier Midwest constr...
Read More >
New Jersey amended its existing WARN Act, otherwise known as the Millville Dallas Airmotive Plant Jo...
Read More >
In a recent article published in The New York Times, Jason Dana, a professor at the Yale School of M...
Read More >
In less than two months the Illinois Cannabis Regulation and Tax Act (the “Act”) will come into ef...
Read More >
One of the ongoing questions from members of Board of Directors is how to resolve the tension betwee...
Read More >